Maarten van Eijk - Dissemin

Language
Login

All papers authored by Maarten van Eijk

This paper is made freely available by the publisher.

2022 Maarten van Eijk

ORCID

, Marit A. C. Vermunt, Erik van Werkhoven, Erica A. Wilthagen, Alwin D. R. Huitema, Jos H. Beijnen

The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2021 Marit A. C. Vermunt

ORCID

, Debbie G. J. Robbrecht

ORCID

, Lot A. Devriese, Julie M. Janssen, Bas Thijssen, Marianne Keessen, Maarten Eijk

ORCID

, Rob Kessels, Ferry A. L. M. Eskens, Jos H. Beijnen, Niven Mehra, Andries M. Bergman

ModraDoc006 , an oral docetaxel formulation in combination with ritonavir ( ModraDoc006 /r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Maarten van Eijk

ORCID

, Dick Pluim, Thomas P. C. Dorlo, Serena Marchetti, Alwin D. R. Huitema, Jos H. Beijnen

Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Maarten van Eijk

ORCID

, René J. Boosman, Alfred H. Schinkel, Alwin D. R. Huitema, Jos H. Beijnen

Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes

Upload

Missing publications? Search for publications with a matching author name.